drugset / Trial / NCT06254261
A Study of RAY1225 in Participants With Obesity
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with Obesity. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.
Timeline
- Start
- 2024-02-21
- Primary completion
- 2025-12-20
- Completion
- 2025-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RAY1225 | Unknown | — | Subcutaneous |